Correlation Between Cyclacel Pharmaceuticals and Arrayit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Arrayit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Arrayit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Arrayit, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Arrayit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Arrayit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Arrayit.

Diversification Opportunities for Cyclacel Pharmaceuticals and Arrayit

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cyclacel and Arrayit is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Arrayit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrayit and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Arrayit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrayit has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Arrayit go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and Arrayit

If you would invest  42.00  in Cyclacel Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  4.00  from holding Cyclacel Pharmaceuticals or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy97.62%
ValuesDaily Returns

Cyclacel Pharmaceuticals  vs.  Arrayit

 Performance 
       Timeline  
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Arrayit 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arrayit has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Arrayit is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Cyclacel Pharmaceuticals and Arrayit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclacel Pharmaceuticals and Arrayit

The main advantage of trading using opposite Cyclacel Pharmaceuticals and Arrayit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Arrayit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrayit will offset losses from the drop in Arrayit's long position.
The idea behind Cyclacel Pharmaceuticals and Arrayit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets